4.7 Article

The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance

Journal

BLOOD
Volume 134, Issue 14, Pages 1154-1158

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2019000855

Keywords

-

Categories

Funding

  1. Japan Society for the Promotion of Science [S2704]
  2. Danish Medical Research Council [FSS 1333-00120B]
  3. Novo Nordisk Foundation (NNF) Copenhagen Bioscience Program [NNF18CC0033666]
  4. Danish Cancer Society [R167-A10877]
  5. Danish National Research Foundation [DNRF82]
  6. Independent Research Fund Denmark [8020-00044]
  7. NNF [NNF16OC0023234, NNF17CC0027852]
  8. Memorial Sloan Kettering Cancer Center (National Institutes of Health, National Cancer Institute) [P30 CA008748]

Ask authors/readers for more resources

KDM4/JMJD2 are H3K9-and H3K36-specific demethylases, which are considered promising therapeutic targets for the treatment of acute myeloid leukemia (AML) harboring MLL translocations. Here, we investigate the long-term effects of depleting KDM4 activity on normal hematopoiesis to probe potential side effects of continuous inhibition of these enzymes. Utilizing conditional Kdm4a/Kdm4b/Kdm4c triple-knockout mice, we show that KDM4 activity is required for hematopoietic stem cell (HSC) maintenance in vivo. The knockout of the KDM4 demethylases leads to accumulation of H3K9me3 on transcription start sites and the corresponding downregulation of expression of several genes in HSCs. We show that 2 of these genes, Taf1b and Nom1, are essential for the maintenance of hematopoietic cells. Taken together, our results show that the KDM4 demethylases are required for the expression of genes essential for the long-term maintenance of normal hematopoiesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Targeting RIOK2 ATPase activity leads to decreased protein synthesis and cell death in acute myeloid leukemia

Jan-Erik Messling, Karl Agger, Kasper L. Andersen, Kristina Kromer, Hanna M. Kuepper, Anders H. Lund, Kristian Helin

Summary: Novel therapies are urgently needed for the treatment of acute myeloid leukemia (AML). A study identified RIOK2 as a potential target for AML treatment, as its loss leads to decreased protein synthesis and apoptosis in leukemic cells.

BLOOD (2022)

Article Cell & Tissue Engineering

SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling

Wei Gu, Hua Wang, Xiaofeng Huang, Judith Kraiczy, Pratik N. P. Singh, Charles Ng, Sezin Dagdeviren, Sean Houghton, Oscar Pellon-Cardenas, Ying Lan, Yaohui Nie, Jiaoyue Zhang, Kushal K. Banerjee, Emily J. Onufer, Brad W. Warner, Jason Spence, Ellen Scherl, Shahin Rafii, Richard T. Lee, Michael P. Verzi, David Redmond, Randy Longman, Kristian Helin, Ramesh A. Shivdasani, Qiao Zhou

Summary: SATB2 plays a crucial role in maintaining the identity of adult colonic stem cells and epithelial cells in mice and humans.

CELL STEM CELL (2022)

Article Biochemistry & Molecular Biology

CpG island reconfiguration for the establishment and synchronization of polycomb functions upon exit from naive pluripotency

Dawei Huo, Zhaowei Yu, Rui Li, Meihan Gong, Simone Sidoli, Xukun Lu, Yuying Hou, Zhongye Dai, Yu Kong, Guifen Liu, Ole N. Jensen, Wei Xie, Kristian Helin, Chaoyang Xiong, Guohong Li, Yong Zhang, Xudong Wu

Summary: This study reveals the dynamic chromatin configuration of CGIs during exit from naive pluripotency and provides a conceptual framework for the spatiotemporal establishment of PcG functions.

MOLECULAR CELL (2022)

Article Biology

Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models

Morteza Chalabi Hajkarim, Ella Karjalainen, Mikhail Osipovitch, Konstantinos Dimopoulos, Sandra L. Gordon, Francesca Ambri, Kasper Dindler Rasmussen, Kirsten Gronbaek, Kristian Helin, Krister Wennerberg, Kyoung-Jae Won

Summary: In this article, the authors introduce a toolkit called compaRe for large-scale multiparameter data analysis. The toolkit integrates quality control, data bias correction, and data visualization methods, and provides faster and more reliable analysis results through a mass-aware gridding algorithm-based similarity analysis. The results show that compaRe can reveal interpatient heterogeneity and recognizable phenotypic profiles, as well as identify multiple types of phenotypic response patterns in drug response data.

ELIFE (2022)

Article Biology

PROSER1 mediates TET2 O-GlcNAcylation to regulate DNA demethylation on UTX-dependent enhancers and CpG islands

Xiaokang Wang, Wojciech Rosikiewicz, Yurii Sedkov, Tanner Martinez, Baranda S. Hansen, Patrick Schreiner, Jesper Christensen, Beisi Xu, Shondra M. Pruett-Miller, Kristian Helin, Hans-Martin Herz

Summary: This study identifies PROSER1 as a regulator of TET2 O-GlcNAcylation and its role in DNA demethylation. PROSER1 mediates the interaction between OGT and TET2, promoting TET2 O-GlcNAcylation and protein stability. Furthermore, PROSER1 colocalizes with UTX, TET1/2, and OGT on many genomic elements, suggesting its involvement in regulating chromatin-associated proteins via OGT-mediated O-GlcNAcylation.

LIFE SCIENCE ALLIANCE (2022)

Article Hematology

BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation

Bing Li, Wenbin An, Hua Wang, Timour Baslan, Shoron Mowla, Aishwarya Krishnan, Wenbin Xiao, Richard P. Koche, Ying Liu, Sheng F. Cai, Zhijian Xiao, Andriy Derkach, Ilaria Iacobucci, Charles G. Mullighan, Kristian Helin, Scott W. Lowe, Ross L. Levine, Raajit K. Rampal

Summary: Leukemic transformation (LT) of myeloproliferative neoplasm (MPN) is often fatal, with TP53 mutational inactivation being the most common event. This study demonstrates that biallelic inactivation of Trp53 leads to LT, specifically a pure erythroleukemia (PEL), arising from the megakaryocyte-erythroid progenitor population. Activation of the bone morphogenetic protein 2/SMAD pathway contributes to abnormal self-renewal of megakaryocyte-erythroid progenitors during LT. The Jak2/Trp53 mutant PEL is characterized by recurrent copy number alterations and DNA damage, and combination WEE1 and poly(ADP-ribose) polymerase inhibition shows potential as a therapeutic strategy.

BLOOD (2022)

Article Multidisciplinary Sciences

H3K4me3 regulates RNA polymerase II promoter-proximal pause-release

Hua Wang, Zheng Fan, Pavel V. Shliaha, Matthew Miele, Ronald C. Hendrickson, Xuejun Jiang, Kristian Helin

Summary: Using mouse embryonic stem cells, we found that acute ablation of shared subunits of the SET1/COMPASS complexes leads to a complete loss of all H3K4 methylation. H3K4me3 turnover is faster than H3K4me1 and H3K4me2, and it relies on KDM5 demethylases. Acute loss of H3K4me3 does not affect transcriptional initiation but results in decreased transcriptional output, increased RNAPII pausing, and slower elongation.

NATURE (2023)

Correction Multidisciplinary Sciences

Publisher Correction: H3K4me3 regulates RNA polymerase II promoter-proximal pause-release (vol 615, pg 339, 2023)

Hua Wang, Zheng Fan, Pavel V. Shliaha, Matthew Miele, Ronald C. Hendrickson, Xuejun Jiang, Kristian Helin

NATURE (2023)

News Item Genetics & Heredity

Catching active enhancers via H2B N-terminal acetylation

Chang Huang, Kristian Helin

Summary: New research suggests that histone H2B N terminus multisite lysine acetylation (H2BNTac) is a significant characteristic of active enhancers and could greatly enhance enhancer prediction accuracy.

NATURE GENETICS (2023)

Article Biochemistry & Molecular Biology

Chromatin regulation of transcriptional enhancers and cell fate by the Sotos syndrome gene NSD1

Zhen Sun, Yuan Lin, Mohammed T. Islam, Richard Koche, Lin Hedehus, Dingyu Liu, Chang Huang, Thomas Vierbuchen, Charles L. Sawyers, Kristian Helin

Summary: Nuclear receptor-binding SET-domain protein 1 (NSD1) is a crucial methyltransferase involved in transcriptional regulation and is dysregulated in diseases like Sotos syndrome. NSD1 associates with H3K36me2 at regulatory elements, particularly enhancers. It promotes enhancer-dependent gene transcription by facilitating RNA polymerase II pause release, affecting cell fate transition and Sotos syndrome development.

MOLECULAR CELL (2023)

Article Multidisciplinary Sciences

An organoid-based CRISPR-Cas9 screen for regulators of intestinal epithelial maturation and cell fate

Stine L. Hansen, Hjalte L. Larsen, Laura M. Pikkupeura, Grzegorz Maciag, Jordi Guiu, Iris Muller, Ditte L. Clement, Christina Mueller, Jens Vilstrup Johansen, Kristian Helin, Mads Lerdrup, Kim B. Jensen

Summary: By studying mouse fetal and adult small intestinal organoids, it was found that rare adult-like cells exist in fetal organoids, suggesting that fetal organoids have the potential to mature but are regulated by certain factors. Through a CRISPR-Cas9 screen, Smarca4 and Smarcc1 were identified as important factors for maintaining the immature progenitor state. This study demonstrates the usefulness of organoid models in identifying factors regulating cell fate and state transitions during tissue maturation and reveals the role of SMARCA4 and SMARCC1 in preventing precocious differentiation during intestinal development.

SCIENCE ADVANCES (2023)

Editorial Material Oncology

EZH2i unlocks PDAC immune surveillance

Helene Damhofer, Kristian Helin

Summary: The dense desmoplastic stroma in pancreatic cancer hinders successful immune-mediated tumor control. Recent research shows that inhibiting EZH2 can relieve the suppressive effect of tumor stroma, allowing for increased expression of pro-inflammatory chemokines after therapy-induced senescence. This boost in NK and T cell recruitment enhances immunological tumor control.

NATURE CANCER (2023)

Article Multidisciplinary Sciences

H3K9 dimethylation safeguards cancer cells against activation of the interferon pathway

Anne Meldgaard Hansen, Ying Ge, Mikkel Bruhn Schuster, Sachin Pundhir, Janus Schou Jakobsen, Adrija Kalvisa, Marta Cecylia Tapia, Sandra Gordon, Francesca Ambri, Frederik Otzen Bagger, Deo Pandey, Kristian Helin, Bo Torben Porse

Summary: The study reveals that H3K9me2 is crucial for the proliferation of AML and its loss leads to activation of the interferon pathway. Mechanistically, destabilization of a complex involving SUV39H1, G9A, and GLP is responsible for this activation.

SCIENCE ADVANCES (2022)

No Data Available